Patents by Inventor Daniel Tartaglia

Daniel Tartaglia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8143592
    Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: March 27, 2012
    Assignee: DRAXIMAGE General Partnership
    Inventor: Daniel Tartaglia
  • Publication number: 20100224791
    Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.
    Type: Application
    Filed: March 15, 2010
    Publication date: September 9, 2010
    Applicant: DRAXIS HEALTH INC.
    Inventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Bournival
  • Publication number: 20100206425
    Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.
    Type: Application
    Filed: April 29, 2010
    Publication date: August 19, 2010
    Applicant: DRAXIS SPECIALITY PHARMACEUTICALS INC.
    Inventor: Daniel Tartaglia
  • Patent number: 7750328
    Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: July 6, 2010
    Assignee: DRAXIMAGE General Partnership
    Inventor: Daniel Tartaglia
  • Patent number: 7700926
    Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: April 20, 2010
    Assignee: Draximage General Partnership
    Inventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Guy Bournival
  • Publication number: 20080142743
    Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.
    Type: Application
    Filed: October 27, 2006
    Publication date: June 19, 2008
    Applicant: DRAXIS SPECIALTY PHARMACEUTICALS INC.
    Inventor: Daniel Tartaglia
  • Publication number: 20080093564
    Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.
    Type: Application
    Filed: July 3, 2007
    Publication date: April 24, 2008
    Applicant: DRAXIS Health Inc.
    Inventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Bournival
  • Publication number: 20070158271
    Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.
    Type: Application
    Filed: December 14, 2006
    Publication date: July 12, 2007
    Applicant: DRAXIS Health Inc.
    Inventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Guy Bournival
  • Patent number: 5306482
    Abstract: Benzalkonium chloride and benzethorium chloride are each useful in radiopharmaceutical preparations (optionally in the presence of a polymyxin or a polymyxin derivative) as bacteriostatic agents which are compatible with anti-oxidants.
    Type: Grant
    Filed: March 3, 1992
    Date of Patent: April 26, 1994
    Assignee: Merck Frosst Canada, Inc.
    Inventors: Daniel Tartaglia, Richard J. Flanagan
  • Patent number: 5227152
    Abstract: Benzalkonium chloride and benzethonium chloride are each useful in radiopharmaceutical preparations as bacteriostatic agents which are compatible with anti-oxidants.
    Type: Grant
    Filed: December 12, 1991
    Date of Patent: July 13, 1993
    Assignee: Merck Frosst Canada, Inc.
    Inventors: Richard J. Flanagan, Daniel Tartaglia
  • Patent number: 5093105
    Abstract: Benzalkonium chloride and benzethonium chloride are each useful in radiopharmaceutical preparations as bacteriostatic agents which are compatible with anti-oxidants.
    Type: Grant
    Filed: April 9, 1991
    Date of Patent: March 3, 1992
    Assignee: Merck Frosst Canada, Inc.
    Inventors: Richard J. Flanagan, Daniel Tartaglia